The age-dependent elevation of miR-335-3p leads to reduced cholesterol and impaired memory in brain, Neuroscience (2018), doi: https://doi.org/10.1016/j.neuroscience. 2018.08.003 This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. 
INTRODUCTION
MicroRNAs (miRNAs), a class of small non-coding transcripts, are considered to be key regulators of gene regulation at post-transcriptional level. MiRNAs have been also shown to be implicated in various pathological diseases, especially neurological diseases such as Alzheimer's disease, Huntington's, autism, multiple sclerosis and Parkinson's disease (Wang et al., 2014 ).
Aging is a major risk factor for most neurodegenerative diseases, and numerous miRNAs are differentially expressed during aging, particularly in aged brains (Smith-Vikos, 2012 ).
Brain is the most cholesterol-rich organ, it requires more cholesterol than any other part of the body due to its higher energy demands (Pfrieger, 2003) . Cholesterol is not only a major constituent of the cell membrane, but also an essential component for synapse and dendrite formation in brain. Cholesterol in brain is primarily produced locally, given that blood brain barrier (BBB) prevents uptake of lipoproteins from the circulation. Neurons have very limited capacity of cholesterol synthesis, as they constitutively rely on astrocytes to deliver cholesterol via lipoproteins. Both 3-hydroxy-3-methylglutaryl-CoA synthase-1 (HMGCS1) and 3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR) are the key rate-limiting enzymes in cholesterol synthesis pathway. HMGCS1 converts acetyl-CoA to (HMG)-CoA, and HMGCR catalyzes (HMG)-CoA toward mevalonic acid, that is a key step in cholesterol biosynthesis. Indeed, disruption of cholesterol synthesis in the brain have been associated with aging (de Chaves et al., 2008) and numerous neurodegenerative diseases (Zhang et al., 2015) .
MicroRNAs are shown to be involved in cholesterol regulation and homeostasis (Sacco and Adeli, 2012; Vickers et al., 2014) . Several miRNAs have been reported for their regulatory roles in cholesterol metabolism (Rotllan and Fernandez-Hernando, 2012) , and some of these miRNA such as miR33 is particularly involved in brain cholesterol metabolism and implicated in related diseases (Jaouen and Gascon, 2016) .
Mi-335 has been reportedly associated with lipid metabolism in liver and white adipose tissues (Nakanishi et al., 2009b) . The differential expression of miR-335-3p has been associated with aging (Kabir et al., 2016; Bai et al., 2011; Tomé et al., 2014) , as well as with neurodegenerative diseases (Cogswell et al., 2008; Denk et al., 2015; Lau et al., 2013) . However, the role of miR-335-3p in brain cholesterol metabolism, particularly during aging, largely remains unknown.
In the present study, we discover that miR-335-3p level is significantly enhanced in aged cultured astrocytes, as well as in hippocampal brains. Gain of function of miR-335-3p leads to a reduction of cholesterol levels by suppressing HMGCR and HMGCS1 levels posttranscriptionally, both are rate-limiting enzymes in cholesterol synthesis pathway. More importantly, knockdown of miR-335-3p in hippocampal brain of aged mice results in restored levels of cholesterol, PSD95 and consequently improved learning and memory. Our findings reveal that miR-335-3p serves as a novel regulator in cholesterol metabolism in the brain, providing a potential therapeutic target for age related neurological diseases. 
EXPERIMENTAL PROCEDURES

Cell culture
Neuro 2a and HEK293T cells were originally from ATCC and cultured with Dulbercco's modified Eagle's medium (DMEM, Gibco) plus 10% fetal bovine serum (FBS, Gibco) and 1% penicillin/streptomycin (P/S, Invitrogen) at 37 under 5% CO2. All cell lines were tested negative for mycoplasma contamination.
Neuron-astrocyte co-cultures
Neuron-astrocyte co-cultures were performed as described previously, with modifications (van . Cortical brains were harvested from postnatal day 1 (P1) wild-type (WT) C57B/6J mice, and digested in PBS containing 0.05% trypsin at 37°C for 10 minutes. Astrocytes were seeded on a poly-D-lysine (Sigma) coated 6-well plate and maintained in DMEM (Gibco) plus 10% FBS (Gibco), 1% sodium pyruvates (Invitrogen) and 1% penicillin/streptomycin (Invitrogen), in CO2 incubator at 37°C. When cells reached confluent, astrocyte culture medium was replaced with neurobasal medium (Gibco) supplemented with B-27 (Gibco), 1% penicillin/streptomycin (Invitrogen). Cortical neurons were prepared from E17 wild-type mice according to previously published , and plated onto the astrocyte monolayer.
Neuron-astrocyte co-cultures (7 DIV) were subjected to lentiviral transduction, followed by atorvastatin (10 µM/L) or cholesterol (50 µM) treatment.
Plasmid construction
miR-335 precursor sequence was PCR amplified from N2a cell genomic DNA and sub-cloned into EcoRI/BamHI restriction sites of the pCDH-EF1 lentivector (Addgenes). A short RNA hairpins (miRZip), that competitively and specifically targets and inhibits miR-335, was subcloned into BamHI/EcoRI restriction sites of pGreenPuro hairpin backbone lentivector (System Biosciences). H1 promoter and miR-335 antisense was PCR amplified from pGreenPuro vector and inserted into Eco53KI/HindIII sites of pAAV-EF1a-DIO-Gcamp6s vector (Addgenes), whereas EF1a promoter was replaced with CamkIIa promoter followed by zsGreen sequence for neuronal visualization. Full-length mouse SFRS2 was PCR amplified from mouse astrocyte derived cDNAs and inserted into the EcoRI/BamHI restriction sites of the pCDH-EF1 lentivector for overexpression. SFRS2 shRNA sequences were annealed and inserted into the BamHI/EcoRI restriction sites of the H1 promoter driven pGreenPuro backbone lentivector.
Lentiviral production
Lentiviral plasmid, together with packaging (pHR'8.2deltaR) and envelope plasmid (pCMV-VSV-G) were transfected into 293T cells. Virus containing medium was harvested 24 h after the transfection and subjected to ultracentrifuge for virus precipitations. Viral titer was determined by qPCR.
AAV production and stereotaxic injection
293T cells were co-transfected with AAV target plasmid, together with pHelper and helper2/9 in a ratio of 2:1:1. Transfection was carried out using PEI (Sigma) as a transfection reagent. Viral titer was determined by qPCR through serial dilutions. Male WT C57BL/6J mice were stereotaxically injected with adenovirus containing miR-335-3p RNAi or control AAV (0.5 µl,
1×10
12 TU/ml ) into the bilateral CA1 area of hippocampus with an air pressure injector system (KDS). The coordinates used for stereotaxic injections was AP -2.3, ML 2.0, DV -1.5 and AP -2.3, ML -2.0, DV -1.5.
RNA immunoprecipitation
Primary cultured astrocytes (12 DIV) were harvested and lysed in PBS plus 1% Triton-X100 (Sigma), followed by ultra-sonication for 2 min (Ningbo Scientz Biotechnology, China). The homogenates were incubated on ice for 15 min and then centrifuged at 13,000 rpm for 10 min, protein concentration of supernatant was determined by BCA Protein Assay (GeneStar). Equal amount of lysates were incubated with protein A/G beads (BioTools) pre-conjugated with SFRS2
antibody or control IgG. Total RNA was extracted from beads and subjected to qPCR analyses.
RNA extraction, Reverse transcription and qPCR
Total RNA was extracted from cells or tissues using TRIzol (Invitrogen) following the manufacturer's instructions. Micro RNA detection was performed as previously described (Zhang J, 2008) , polyA tail was added to 3' end of RNA using poly A polymerase (NEB). Tailed RNA was reverse transcribed using HiScript® II Reverse Transcriptase (Vazyme) in the presence of an anchor RT primer: cgactcgatccagtctcagggtccgaggtattcgatcgagtcgcacttttttttttttv.
Quantitative PCR was performed with AceQTM qPCR SYBR Green Master Mix (Vazyme) on
LightCycler 96 system (Roche) according to standard procedures. The real-time value for each sample was averaged and compared using the CT method, where the amount of target RNA (2−∆∆CT) was normalized to an endogenous reference (∆CT) and related to the amount of target gene in tissues or cells, which was set as the calibrator at 1.0.
Western blot and Densitometry analysis
Cells or tissues were lysed in 1% Triton-X 100 containing PBS, plus cocktail protease inhibitors (BioTool), then subjected to sonication for 2 min and incubation on ice for 15 min. Lysates were then centrifuged at 14,000 rpm for 10 min, protein level of supernatant was determined using BCA Protein Assay Kit (GeneStar). Equal amount of proteins were subjected to SDS-PAGE.
The immunoreactive bands were visualized by enhanced chemiluminescence (Advansta) and detected by ChemiScope (CLiNX). The densitometric analyses of immunoreactive bands were performed using Image J (National Institutes of Health, Bethesda, MD, USA).
Cholesterol assay
Total cholesterol level was determined using Amplex® Red Enzyme Assays (Invitrogen) following manufacturer's instructions.
Luciferase reporter assay
Full-length WT or mutant 3ˊUTR of SFRS2 and HMGCS1 were PCR amplified and inserted into NheI/XbaI restriction sites of pmirGlo dual luciferase vector (Promega) according to manufacturer's protocol. N2a cells were transfected with control or miR-335-3p RNAi, 24 h later, each luciferase construct was seperately introduced into these cells. Cells were harvested 48 h after the initial transfection, and cell lysates were incubated with luciferase substrate (Promega). Luciferase activity was measured and data were presented as relative fold change over control.
Animals
Male C57B/6J mice were purchased from Model Animal Research Center of Nanjing University and were housed under controlled temperature and light condition (12 hours light/dark). The mice were kept in standard laboratory mice cage and given ad libitum access to food and water. 2 month (2M) and 24 month (24M) old mice were used to represent young (2M) and aged (24M) mice respectively. 15 month old (15M) mice were used for AAV mediated shRNA or RNAi delivery into hippocampal brain. Protocols involving mice were approved by the Institutional Animal Care and Use Committee at the University of Science and Technology of China.
Behavioral assay
Novel object recognition test (NOR)
Object location recognition, also known as the recognition memory test, was performed according to previously established protocol to assess working memory (Li et al., 2018) . During habituation phase, the mice were first kept in an open acrylic box (30 cm × 20 cm × 30 cm) for 10 min to familiarize with the test apparatus. During the training phase, mice were placed in the middle of the test box containing two identical cubes, and they were allowed to explore for 10 min. After the training phase, the mice were returned back to their home cages for 1 h. The mice were again placed in the test chamber, where one cube was replaced with ball, followed by 5 min exploration. Novel and familial object exploration time were recorded, and cognitive index (CI) was calculated as CI=[(novel object exploration time)/ (familial object exploration time + novel object exploration time) × 100].
Morris Water Maze test
The Morris water maze test was performed according to published protocol (Li et al., 2018) . The whole assessment was divided into two phases, training phase of consecutive five days followed by a probe test on day six. The test was performed in a circular pool with four equal quadrants (NE, NW, SE and SW), that was filled with opaque water (30 cm deep) at a constant temperature of 21-22°C. A 12 cm platform was placed in the southwest (SW) quadrant, equidistant from the center and wall. The mice were given four trials (60 sec each) per day for 5 days during training phase, and on day six, the hidden platform was removed and mice were placed from quadrant, opposite to that where the platform had been, and mice were allowed to swim freely for 90 sec.
The probe trial was recorded with a digital video camera placed above the center of the pool and the behavioral parameters were analyzed using Ethovision XT 11 software (Noldus).
Immunofluorescence staining
Primary cultured astrocytes on cover slip were washed 3 times with PBS, fixed in 4% PFA for 15 min, followed by permeabilization with 0.2% Triton X-100 containing PBS. Cells were subjected to blocking with 2% BSA in PBST for 30 min. Brain tissues sections mounted on glass slides were washed 3 times in TBS, permeabilized with PBS buffer containing 0.25% Triton X-100 and blocked in 5% BSA in PBS. After blocking, both cells and tissue sections were incubated with anti-GFAP antibody at 4°C overnight, followed by Alexa-conjugated secondary antibody (anti-rabbit Alexa Fluor 488 for astrocyte and anti-rabbit Alexa Fluor 594 for brain sections). Fluorescence signals were detected with CCD camera mounted onto U-CB5S microscope system (Olympus).
Statistical Analysis
Statistical comparisons were performed in GraphPad Prism 5.0, using Student's t-test or two-way ANOVA when appropriate. Values were represented as the mean ± standard error of the mean,
and P values <0.05 (indicated by asterisk) were considered significant. -335-3p level is increased during aging in vitro and in vivo, with a corresponding decrease of cholesterol level.
RESULTS
MiR
To examine the age-associated differential expression of miR-335 in astrocytes, we assessed its levels in young (7D) and aged (35D) primary cultured astrocytes using qPCR. We found that levels of miR-335-3p, but not miR-335-5p, were significantly enhanced in aged cultured astrocytes (Fig. 1A) . We also observed a similar increase of miR-335-3p in hippocampal brain of aged mice (24M), when compared to young controls (2M) (Fig. 1B) . Cholesterol metabolism is believed to be altered during natural course of aging, we therefore examined the cholesterol levels of young and aged astrocytes and brains. We found that cholesterol levels were significantly decreased both in aged cultured astrocytes (35D) (Fig. 1C ) and in hippocampal brains of aged mice (24M) (Fig. 1D ). To determine how cholesterol metabolism was altered, we measured the levels of HMGCR and HMGCS1, both are essential enzymes in cholesterol synthesis pathway. We observed a significant decrease of both HMGCR and HMGCS1 levels in aged cultured astrocytes (35D) (Fig. 1E ) and in hippocampal brains from aged mice (24M) (Fig.   1G ). The densitometric analyses also supported these notions (Fig. 1F, H) . Postsynaptic density protein 95 (PSD95) is exclusively located in the post synaptic density of neurons and plays an important role in synaptic plasticity and long-term potentiation. In our study, we found that PSD95 levels were substantially decreased in the hippocampus of aged mice (24M) (Fig. 1G, H ), indicating that neuronal function was declined in aged mouse. Taken together, these findings demonstrate that miR-335-3p level is up-regulated during aging, and it may associate with the disruption of cholesterol metabolism in aged brains.
MiR-335-3p negatively regulates HMGCS1 and HMGCR levels in cholesterol synthesis pathway, consequently cholesterol level.
We next investigated whether miR-335-3p is involved in cholesterol metabolism. Using lentiviral delivered antisense miRNA to knockdown miR-335-3p ( Fig. 2A) , we observed a substantial elevation of cellular cholesterol in aged cultured astrocytes (35DIV) (Fig. 2D ).
HMGCR and HMGCS1 are known as rate-limiting enzymes in cholesterol biosynthesis, whereas SFRS2, a member of SR family proteins, is a multifunctional RNA binding protein and recently reported to have a regulatory role in cholesterol synthesis and metabolism (Cheng et al., 2016) .
Given that the seed region of miR-335-3p base-pairs to binding sites on 3'UTR of HMGCR, HMGCS1 and SFRS2, as predicted by TargetScan (www.targetscan.org), we accordingly assessed the levels of HMGCR, HMGCS1 and SFRS2, and found that all of them were significantly increased in the absence of miR-335-3p (Fig. 2B, C) . Moreover, levels of glial fibrilar acidic protein (GFAP), the astrocyte specific marker, have showed gradual increase during aging progression (Gross et al., 1991; Nichols et al., 1993) . In our study, we found that levels of GFAP were significantly decreased in cultured astrocytes with miR-335-3p deficiency, as indicated by immunostaining of GFAP (Fig. 2E) . Conversely, to investigate the gain of function of miR-335-3p, we introduced miR-335-3p into cultured astrocytes using lentiviral delivery technology (Fig. 2F ). We observed that cellular cholesterol was significantly decreased in miR-335-3p administered cultured astrocytes (Fig. 2I) . Levels of HMGCS1, SFRS2 and HMGCR were also found significantly decreased, as indicated by Western blot and subsequent densitometric analyses (Fig. 2G, H) . Moreover, GFAP was significantly activated in cultured astrocytes in the presence of miR-335-3p (Fig. 2J) . Taken together, these findings demonstrate that miR-335-3p modulates cholesterol metabolism by altering levels of HMGCS1, SFRS2 and HMGCR in astrocytes.
MiR-335-3p mediated cholesterol loss results in reduction of PSD95 in neuron and astrocyte mixed cultures.
Emerging evidence has demonstrated that astrocytes, a major population of glia cells in the brain, play essential roles in neuronal functions. To determine whether miR-335-3p affects neuronal function by mediating cholesterol metabolism in astrocytes, we seeded neurons onto the monolayer of astrocytes with miR-335-3p overexpression to create neuron-astrocyte mixed cultures (Fig. 3A) . Consistent with previous findings, we observed a significant decrease of cellular cholesterol in miR-335-3p administered mixed cultures (Fig. 3D ). In addition, we also found that levels of HMGCS1, HMGCR and SFRS2 were significantly decreased in those cultures (Fig. 3B ). More importantly, PSD95 levels were found decreased substantially, indicating that neuronal synapse functions were deeply affected (Fig. 3B ). The densitometric analyses also supported those conclusions (Fig. 3C ). Taken together, these findings show that miR-335-3p regulates neuronal synapse plasticity by modulating cholesterol metabolism in astrocytes.
MiR-335-3p directly binds to 3'UTR of HMGCS1 and SFRS2, and represses their expressions.
Given that miR-335-3p harbors binding sites to 3'UTR of SFRS2 and HMGCS1 respectively, as indicated in schematic (Fig. 4A) , we next evaluated whether miR-335-3p directly binds to the 3'UTR of SFRS2 and HMGCS1 mRNA through these sequences. We generated luciferase reporter constructs containing full-length 3'UTR of HMGCS1 or SFRS2, along with their respective mutant 3'UTR, as indicated in schematic (Fig. 4A ) . Constructs containing wild type or mutant 3'UTR were introduced into control or miR-335-3p administered N2a cells. Luciferase assay demonstrated that wild type, but not mutant 3'UTR, showed decreased luciferase activities in miR-335-3p administered cells, when compared to controls (Fig. 4B ). More importantly, mRNA levels of HMGCS1 and SFRS2 were significantly decreased in miR-335-3p
overexpressed cells, as a result of direct binding of miR-335-3p to HMGCS1 and SFRS2 (Fig.   4C ). Conversely, miR-335-3p knockdown cells introduced with wild type 3'UTR, showed significantly increased luciferase activities, whereas miR-335-3p knockdown cells introduced with mutant 3'UTR showed similar luciferase activities to controls (Fig. 4D ). In addition, mRNA levels of both HMGCS1 and SFRS2 were increased in the absence of miR-335-3p (Fig. 4E) .
Similarly, mRNA levels of HMGCS1 and SFRS2 were significantly enhanced in miR-335-3p deficient cells. In summary, miR-335-3p directly binds to 3'UTR of HMGCS1 and SFRS2, and suppresses their expressions.
SFRS2 binds to 3'UTR of HMGCR and stabilizes its mRNA level.
As a RNA binding protein, SFRS2 is involved in regulation of splicing, translation and stability of target mRNA (McFarlane et al., 2015; Qian et al., 2011) through binding of its RNA recognition motif (RRM) and target mRNA. Moreover, HMGCR mRNA is stabilized by RNA binding protein (Yu et al., 2013) . Given that SFRS2 contains RNA recognition domain, it could base pair with 3'UTR of HMGCR mRNA by direct binding (Fig. 5A) . We next investigated whether miR-335-3p regulates HMGCR levels through SFRS2. Cultured astrocyte lysates were subjected to immunoprecipitation by SFRS2 antibody, following by qPCR analyses of SFRS2-bound RNA. We observed that SFRS2 was successfully immunoprecipitated and detected in Western blots (Fig. 5A) , and HMGCR mRNA was significantly enriched by SFRS2 antibody, whereas GAPDH showed no significant enrichment, as compared to control IgG (Fig. 5B) . To further confirm that HMGCR is indeed the regulatory target of SFRS2, we assessed HMGCR levels in SFRS2 administered or knockdown cultured astrocytes. Our findings revealed that both mRNA and protein levels of HMGCR were significantly decreased in the absence of SFRS2 (Fig. 5C, G) , and increased in the presence of SFRS2 (Fig. 5E, H) , suggesting that SFRS2 positively regulates HMGCR level. The densitometric analyses also supported these notions (Fig. 5D, F) . Altogether, SFRS2 binds to HMGCR mRNA and alters its levels.
Deficiency of miR-335-3p in hippocampal brain leads to increased cellular cholesterol and improved spatial learning and memory.
To investigate the role of miR-335-3p in vivo, we knockdown miR-335-3p in the hippocampus of 15-month old mice (15M) by using AAV delivered miR-335-3p antisense. Three month after AAV injection, mice were subjected to behavioral tests to assess their learning and memory. In the Morris water maze test, mice with miR-335-3p deficiency in the hippocampus located the hidden platform with significantly less travel time during the training phase (n=6 for each group) (Fig. 6E) . During the probe trial, these mice spent considerably less time reaching the target quadrant ( Fig. 6F ) and crossed this target quadrant more often, when compared to controls (Fig.   6G ). In the novel object recognition test, mice lacking miR-335-3p in hippocampal brains spent significantly longer time on object exploration in a novel context than controls (Fig. 6H) .
Hippocampal brains were then isolated from control and miR-335-3p deficient mice, and subsequently subjected to RNA, protein and cholesterol assays. We first verified miR-335-3p levels in hippocampal brains, indicating a successful application of AAV (Fig. 6A ). Cholesterol assay revealed that cholesterol levels were significantly increased in the absence of miR-335-3p (Fig. 6B) . Moreover, protein levels of HMGCS1, HMGCR, SFRS2 and PSD95 were significantly elevated in miR-335-3p deficient hippocampal brains (Fig. 6C ). This was also evident by densitometric analyses (Fig. 6D) . Consistent with previous immunostaining of GFAP in cultured cells, significant astrocyte deactivation was observed upon knockdown of miR-335-3p in the hippocampus of mouse brain (Fig. 6I) . In summary, these findings demonstrate that depletion of miR-335-3p improves learning and memory in aged mice, primarily by modulating levels of HMGCS1, HMGCR, SFRS2 and subsequently cholesterol metabolism.
Atorvastatin reduces the elevated PSD95 levels led by miR-335-3p deficiency, whereas supplementation of cholesterol restores the decreased PSD95 levels caused by miR-335-3p overexpression.
To further investigate whether the regulatory role of miR-335-3p in neuronal synapse functions is cholesterol dependent, we next either depleted cholesterol in cells with miR-335-3p depletion, or supplied cholesterol to cells with miR-335-3p administration. Neuron-astrocyte co-cultures were subjected to miR-335-3p knockdown, followed by treatment of HMGCR inhibitor atorvastatin to deplete cholesterol. We found that atorvastatin reversed the enhanced PSD95 level led by miR-335-3p deficiency to the similar level of controls (Fig. 7A, B) . Conversely, when cholesterol was supplied to miR-335-3p administered neuron-astrocyte co-cultures, PSD95 levels were restored to the similar levels of controls (Fig. 7C, D) . These results suggest that functions of miR-335-3p in neuronal synapses are highly dependent on cholesterol metabolism.
DISCUSSION
Astrocytes are the most abundant glial subtype in the brain. The level of GFAP, an astrocyte marker, increases progressively during natural aging course, in addition, astrocytes also become persistently activated upon aging (Goss et al., 1991; Nichols et al., 1993) . These observations are believed coming from the enhanced load of oxidative damage and inflammatory processes, that occurs throughout the brain during aging (Morgan et al., 1997) . The gene expression pattern of aging astrocytes partially overlap with reactive astrocytes, that were induced by injuries, indicating a mild to moderate reactive state occurs in aging astrocytes (Boisvert et al., 2018) .
Accordingly, the increase of GFAP is considered as one of the early responses to metabolic and oxidative stress in aged brains (Bellaver et al., 2017; Clarke et al., 2018) . In this study, we identify miR-335, whose levels are substantially elevated in aged cultured astrocytes and hippocampal brains. Administration of miR-335 in either cultured astrocytes or hippocampal brains leads to a significant activation of astrocytes.
Aging brains gradually exhibit cognitive decline, accompanied by reduced neuronal synaptic functions. Astrocytes also serve as key regulators in structural and functional integrity of neurons over the lifespan (Halassa et al., 2014) . Enhanced GFAP during aging is regarded to be associated with declined synaptic functions ( Lefrancois et al., 1997) . Astrocytes are the primary source of cholesterol synthesis in the brain, and neurons constitutively rely on astrocytes for cholesterol supplying. Lacking of cholesterol production in astrocytes may lead to decreased synaptic functions, indicating astrocyte-derived cholesterol is essential for neuronal synapse function (Mauch et al., 2001; . Interestingly, levels of astrocytes homeostasis genes mostly remain unaltered during aging, however, the capacity of cholesterol synthesis were significantly down-regulated in aging astrocytes (Boisvert et al., 2018) , this could explain the general decreased cholesterol level in aging brain. Moreover, the regulation of cholesterol metabolism in astrocytes and how it affects neuronal synaptic functions mostly remains unknown.
Cholesterol is an essential component in physiological and pathological conditions. Disorders of cholesterol metabolism has been linked to multiple neurological diseases, such as Alzheimer's disease (Yoon et al., 2016) , Autism spectrum disorders (ASDs) (Cartocci et al., 2018) . HMGCR is the key and rate-limiting enzyme of cholesterol biosynthesis process, also one of the most intensively studied proteins. In addition to short-term regulation, achieved by altering enzyme activities through phosphorylation/dephosphorylation cycles, HMGCR is also subjected to longterm regulation through transcriptional and post-transcriptional regulations (Xu et al., 2005) . The regulation of HMGCR is well characterized in peripheral tissue such as liver, however, little is known in CNS. Cholesterol biosynthesis was modulated differently in various brain regions, implying cholesterol homoeostasis is precisely maintained to meet the regional needs (Segatto et al., 2012; Segatto et al., 2013) . In our study, we focus on hippocampal brain, a brain area critical for learning and memory. It is also one of the most vulnerable brain regions to damages.
MicroRNAs (miRNAs) are small endogenous non-coding RNAs (20-22 nucleotide long). Its typical function is to repress translation or promote degradation of target mRNA, by binding to the specific region of 3' untranslated region of target mRNAs, controlling a variety of biological processes (Bartel et al., 2009) . Mounting research has showed that miRNAs play regulatory roles in cholesterol/lipid metabolism of peripheral tissues (Fernandez-Hernando et al., 2011) , some evidence has also demonstrated that miRNAs serve as key regulators in brain cholesterol metabolism. However, most the studies focus on lipid transporting protein like ApoE and ABCA1, little is known for cholesterol synthesis genes (Yoon et al., 2016) . Here, in our study, we demonstrate that miR-335-3p post-transcriptionally inhibits HMGCS1 and HMGCR levels in cholesterol biosynthesis pathway, consequently reduces cholesterol levels.
Levels of miR-335-3p have been found significantly increased in ASD by high-throughput sequencing (Hicks et al., 2016) , and other studies have also reported that altered brain cholesterol metabolism is also observed in ASD rats (Cartocci et al., 2018) . All the evidence leads us to study the regulatory role of miR-335 in cholesterol metabolism. More importantly, miR-335 is tightly related to cholesterol metabolism in liver (Nakanishi et al., 2009) , however, the role of miR-335 in brain cholesterol metabolism has not been established yet.
Atorvastatin treated mice exhibited impaired cognitive functions, accompanied by significant decrease of post-synaptic density protein-95 (PSD95) (Schilling et al., 2014) , indicating that cholesterol metabolism is directly linked to synapse functions. In this study, we found that miR-335-3p decreases PSD95 levels in neuron-astrocyte co-cultures, as well as in hippocampal brains.
Reduction of miR-335 in hippocampal brains partially restores the declined cognitive functions in aged mice. Our findings elucidate a novel function of miR-335-3p in cholesterol mediated regulation of synaptic function and memory in aging.
The observed decrease of PSD95 led by miR-335 is very likely to be an indirect effect, given that miR-335 contains no direct binding sites to PSD95 mRNA, therefore we speculated that the regulation is probably through other targets, such as cholesterol. To test this hypothesis, we supplemented cholesterol to miR-335-3p administered neuron-astrocyte co-cultures and observed that PSD95 levels were successfully restored. Conversely, depletion of cholesterol in miR-335 deficient co-cultures led to reduction of PSD95 to control levels, indicating that cholesterol levels were tightly linked to PSD95 levels. Consistently, mounting evidence has suggested that cholesterol in general has a beneficial effect on aging or neurodegenerative diseases (Ferris et al., 2017; Martin et al., 2014; Silverman and Schmeidler, 2018) .
Our results elucidate a novel function of miR-335-3p in cholesterol metabolism, and subsequently cholesterol mediated regulation of synaptic function and memory in aging. Our study provides a novel way to understand cholesterol metabolism in aging.
CONCLUSIONS
MiR-335-3p has been implicated in aging and age-related neurological diseases. However, the role of miR-335-3p in disrupted cholesterol metabolism during aging remains largely unknown.
In our current study, we demonstrate that miR-335-3p suppresses cholesterol by inhibiting expressions of HMGCS1 and HMGCR in astrocytes. This, in turn, affects neuronal synapse functions. Reduction of miR-335-3p in aged hippocampal brains leads to rescued cognitive impairment and neuronal synaptic functions during aging. GAPDH was included as input controls. *P<0.05; **P<0.01; ***P<0.001 by ANOVA or Student's t test;; error bars denote means ± SEM. 
